Inari Medical (NARI)
(Delayed Data from NSDQ)
$44.10 USD
-2.15 (-4.65%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $44.10 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum B VGM
Inari Medical, Inc. (NARI) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$64.46 | $93.00 | $47.00 | 39.37% |
Price Target
Based on short-term price targets offered by 13 analysts, the average price target for Inari Medical, Inc. comes to $64.46. The forecasts range from a low of $47.00 to a high of $93.00. The average price target represents an increase of 39.37% from the last closing price of $46.25.
Analyst Price Targets (13)
Broker Rating
Inari Medical, Inc. currently has an average brokerage recommendation (ABR) of 1.64 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 14 brokerage firms. The current ABR compares to an ABR of 1.54 a month ago based on 13 recommendations.
Of the 14 recommendations deriving the current ABR, nine are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 64.29% and 7.14% of all recommendations. A month ago, Strong Buy made up 69.23%, while Buy represented 7.69%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 9 | 9 | 9 | 8 | 7 |
Buy | 1 | 1 | 1 | 1 | 2 |
Hold | 4 | 4 | 3 | 3 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.64 | 1.64 | 1.54 | 1.58 | 1.55 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/3/2024 | SVB Securities | Michael Kratky | Not Available | Hold |
8/26/2024 | Piper Sandler | Adam C Maeder | Hold | Hold |
7/31/2024 | Robert W. Baird & Co. | David Rescott | Strong Buy | Strong Buy |
7/31/2024 | Wells Fargo Securities | Lawrence H Biegelsen | Strong Buy | Strong Buy |
7/31/2024 | Canaccord Genuity | William J Plovanic | Strong Buy | Strong Buy |
7/25/2024 | William Blair | Margaret Kaczor | Not Available | Strong Buy |
7/18/2024 | Needham & Company | Michael Matson | Moderate Buy | Hold |
7/16/2024 | Truist Securities | Richard Newitter | Hold | Hold |
1/7/2024 | BTIG | Marie Thibault | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.64 |
ABR (Last week) | 1.64 |
# of Recs in ABR | 14 |
Average Target Price | $64.46 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 63 of 253 |
Current Quarter EPS Est: | -0.11 |
NARI FAQs
Inari Medical, Inc. (NARI) currently has an average brokerage recommendation (ABR) of 1.64 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 14 brokerage firms.
The average price target for Inari Medical, Inc. (NARI) is $64.46. The current on short-term price targets is based on 6 reports.
The forecasts for Inari Medical, Inc. (NARI) range from a low of $47 to a high of $93. The average price target represents a increase of $39.37 from the last closing price of $46.25.
The current UPSIDE for Inari Medical, Inc. (NARI) is 39.37%
Based on short-term price targets offered by 13 analysts, the average price target for Inari Medical, Inc. comes to $64.46. The forecasts range from a low of $47.00 to a high of $93.00. The average price target represents an increase of 39.37% from the last closing price of $46.25.